Latest Breaking News On - Crinetics pharmaceuticals stock - Page 1 : comparemela.com

Crinetics Pharmaceuticals (NASDAQ:CRNX) Receives Buy Rating from HC Wainwright

Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They presently have a $60.00 price target on the stock. HC Wainwright’s price objective points to a potential upside of 18.72% from the stock’s previous […]

United statesRobertw bairdMarc wilsonStephenf betzPrincipal financial group incCrinetics pharmaceuticalsCrinetics pharmaceuticals stockMirae asset global investments coSecurities exchange commissionVictory capital management incInstitutional investors weigh in on crinetics pharmaceuticalsCrinetics pharmaceuticals incAnalyst recommendations for crinetics pharmaceuticalsNews ratings for crinetics pharmaceuticals dailyCantor fitzgeraldGet free report

Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High at $51 60

Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High at $51 60
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Richard scott struthersStephenf betzRobertw bairdCrinetics pharmaceuticals incJennison associatesSecurities exchange commissionCrinetics pharmaceuticalsVictory capital management incCharles schwab investment management incNews ratings for crinetics pharmaceuticals dailyCrinetics pharmaceuticals stockCampbell co investment adviserFisher asset managementGet free reportScott struthersExchange commission

Short Interest in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Rises By 6 3%

Short Interest in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Rises By 6 3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dana pizzutiMarc wilsonInsider transactions at crinetics pharmaceuticalsCampbell co investment adviserCrinetics pharmaceuticals stockMorgan stanleyCrinetics pharmaceuticalsVictory capital management incCharles schwab investment management incNews ratings for crinetics pharmaceuticals dailyCrinetics pharmaceuticals incSecurities exchange commissionSwiss national bankCrinetics pharmaceuticals company profileVivo capitalGet free report

Brokerages Set Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Price Target at $54 17

Brokerages Set Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Price Target at $54 17
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMatthewk fustRichard scott struthersNews ratings for crinetics pharmaceuticals dailyCrinetics pharmaceuticalsAnalyst recommendations for crinetics pharmaceuticalsGoldman sachs group incCantor fitzgeraldSecurities exchange commissionVanguard group incFisher asset managementCrinetics pharmaceuticals company profileCrinetics pharmaceuticals incCrinetics pharmaceuticals stockInstitutional trading of crinetics pharmaceuticalsMorgan stanley

Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Short Interest Update

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 5,010,000 shares, an increase of 5.7% from the February 29th total of 4,740,000 shares. Based on an average daily volume of 745,500 shares, […]

Stephenf betzMarc wilsonMorgan stanleyBlackrock incInstitutional investors weigh in on crinetics pharmaceuticalsCrinetics pharmaceuticals stockSecurities exchange commissionCantor fitzgeraldJennison associatesCrinetics pharmaceuticals incVanguard group incJefferies financial groupCrinetics pharmaceuticalsCrinetics pharmaceuticals company profileNews ratings for crinetics pharmaceuticals dailyGet free report